BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30687892)

  • 1. Pretreatment
    Abe Y; Narita K; Kobayashi H; Kitadate A; Miura D; Takeuchi M; O'uchi E; O'uchi T; Matsue K
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1325-1333. PubMed ID: 30687892
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Jung SH; Kwon SY; Min JJ; Bom HS; Ahn SY; Jung SY; Lee SS; Park MR; Yang DH; Ahn JS; Kim HJ; Lee JJ
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):107-115. PubMed ID: 30187105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary Abnormalities in Appendicular Skeletons Detected With
    Abe Y; Narita K; Kobayashi H; Kitadate A; Takeuchi M; O'uchi T; Matsue K
    AJR Am J Roentgenol; 2019 Oct; 213(4):918-924. PubMed ID: 31216203
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of semi-quantitative parameters of
    Wan B; Zhang S; Wang P; Deng P; Dai W
    Ann Nucl Med; 2023 Mar; 37(3):155-165. PubMed ID: 36528697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Chen Z; Yang A; Chen A; Dong J; Lin J; Huang C; Zhang J; Liu H; Zeng Z; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1926-1936. PubMed ID: 38286937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low hexokinase-2 expression-associated false-negative
    Abe Y; Ikeda S; Kitadate A; Narita K; Kobayashi H; Miura D; Takeuchi M; O'uchi E; O'uchi T; Matsue K
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1345-1350. PubMed ID: 30903198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of [
    Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Baseline
    Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
    Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of
    Han S; Woo S; Kim YI; Yoon DH; Ryu JS
    Eur Radiol; 2021 Jan; 31(1):152-162. PubMed ID: 32809165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of
    Ahn SY; Park HK; Moon JH; Baek DW; Cho HJ; Sohn SK; Kang SR; Min JJ; Bom HS; Hong CM; Jeong SY; Song GY; Yang DH; Ahn JS; Kim HJ; Jung SH; Lee JJ
    Int J Hematol; 2021 May; 113(5):668-674. PubMed ID: 33475961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Total Lesion Glycolysis by
    McDonald JE; Kessler MM; Gardner MW; Buros AF; Ntambi JA; Waheed S; van Rhee F; Zangari M; Heuck CJ; Petty N; Schinke C; Thanendrarajan S; Mitchell A; Hoering A; Barlogie B; Morgan GJ; Davies FE
    Clin Cancer Res; 2017 Apr; 23(8):1981-1987. PubMed ID: 27698001
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective Evaluation of Magnetic Resonance Imaging and [
    Moreau P; Attal M; Caillot D; Macro M; Karlin L; Garderet L; Facon T; Benboubker L; Escoffre-Barbe M; Stoppa AM; Laribi K; Hulin C; Perrot A; Marit G; Eveillard JR; Caillon F; Bodet-Milin C; Pegourie B; Dorvaux V; Chaleteix C; Anderson K; Richardson P; Munshi NC; Avet-Loiseau H; Gaultier A; Nguyen JM; Dupas B; Frampas E; Kraeber-Bodere F
    J Clin Oncol; 2017 Sep; 35(25):2911-2918. PubMed ID: 28686535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients].
    Wang CY; Wu L; Sun CT; Wang X; Xia B; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(4):301-306. PubMed ID: 30669718
    [No Abstract]   [Full Text] [Related]  

  • 17. Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On
    Cho HJ; Baek DW; Kim JH; Lee J; Chung YK; Jung SH; Song GY; Ahn SY; Ahn JS; Yang DH; Lee JJ; Kim HJ; Hong CM; Jeong SY; Min JJ; Sohn SK; Moon JH
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):113-120. PubMed ID: 34598908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy.
    Paschali A; Panagiotidis E; Triantafyllou T; Palaska V; Tsirou K; Verrou E; Υiannaki E; Markala D; Papanikolaou A; Pouli A; Konstantinidou P; Chatzipavlidou V; Terpos E; Katodritou E
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1487-1497. PubMed ID: 33099659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of
    Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
    Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostication system based on clinical parameters and [
    Li J; Zhang X; Qin C; Sun X; Xu X; Cao G; Gai Y; Sun C; Hu Y; Lan X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1665-1670. PubMed ID: 36576511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.